Valowin 133.5mg/58mg Tablet

ਉਤਪਾਦ ਝਲਕ

About Valowin 133.5mg/58mg Tablet

Valowin 133.5mg/58mg Tablet is a prescription medication that combines sodium valproate and valproic acid in a single tablet formulation. The drug is used primarily to treat epilepsy and to control seizures in patients with various seizure disorders. It is also prescribed for the management of bipolar disorder, helping to stabilize mood swings and prevent manic episodes. The tablet is taken orally, usually once or twice daily, depending on the prescribing physician’s instructions. The dosage and frequency are tailored to each patient’s condition and response to therapy. Patients should follow the prescribed schedule and not alter the dose without medical advice. The medication is available in tablet form, which is convenient for daily use and easy to swallow. It is important to take the tablet with food or a full glass of water to reduce the risk of stomach upset. The product is manufactured under strict quality controls to ensure safety and efficacy for patients who require long‑term treatment for seizure control or mood stabilization.

Key Benefits & Uses

• Effective seizure control in patients with epilepsy.
• Stabilizes mood in individuals with bipolar disorder.
• Convenient single‑tablet formulation for daily use.

Active Ingredient & Action

The active components of Valowin 133.5mg/58mg Tablet are sodium valproate and valproic acid. Sodium valproate is a salt form that enhances the drug’s bioavailability, while valproic acid is the active acid that modulates neuronal excitability. Together, they increase the concentration of gamma‑aminobutyric acid (GABA) in the brain, which helps to dampen abnormal electrical activity and reduce the frequency of seizures. The combination also affects voltage‑gated sodium channels, further stabilizing neuronal membranes. This dual mechanism contributes to the medication’s effectiveness in both seizure control and mood regulation.

Important Notes

Patients should inform their healthcare provider of any other medications they are taking, as drug interactions can occur. Regular blood tests are recommended to monitor liver function and drug levels, ensuring safety during long‑term use. The medication should not be stopped abruptly, as this may trigger rebound seizures or mood instability. Pregnant women or those planning pregnancy should discuss the risks and benefits with their doctor, as valproate can affect fetal development. If any adverse reactions such as dizziness, nausea, or changes in mood occur, patients should seek medical advice promptly. The tablet should be stored at room temperature, away from moisture and direct sunlight, and kept out of reach of children.